Drug-tolerant persister cells in cancer: bridging the gaps between bench and bedside

Area of Science:

• Oncology
• Cancer Biology
• Translational Medicine

Background:

• Drug-tolerant persister (DTP) cells are a significant barrier to achieving long-term cancer remission.
• The biological mechanisms and clinical significance of DTP cells are not yet fully understood.
• Current research models often fail to capture the complexity of DTP cell behavior in a clinical setting.

Purpose of the Study:

• To identify critical knowledge gaps that impede the clinical translation of DTP cell research.
• To advocate for a shift from reductionist research models to integrative, patient-aligned approaches.
• To highlight the importance of understanding DTP cell biology for developing effective cancer therapies.

Main Methods:

• This study is a perspective piece, synthesizing current knowledge and identifying research gaps.
• It involves a critical review of existing literature on drug-tolerant persister cells in cancer.
• The approach emphasizes conceptual frameworks for future research directions.

Main Results:

• Key gaps exist in understanding DTP cell heterogeneity and their role in treatment resistance.
• Reductionist models oversimplify DTP cell biology, hindering clinical application.
• There is a pressing need for research that integrates diverse data types and patient-specific contexts.

Conclusions:

• Overcoming DTP cell-mediated treatment resistance requires moving beyond simplistic models.
• Integrative, patient-aligned research strategies are essential for uncovering actionable biomarkers.
• Developing novel therapeutic approaches targeting DTP cells is critical for durable cancer remission.